Atlas Trials

Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment

Clinical trial NCT04177303 · UNKNOWN

Trial details

NCT number
NCT04177303
Sponsor
Hellenic Institute for the Study of Sepsis
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2019-11-29
Primary completion
2022-11-29
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.